Nadolol: Clinical Trials

5 trials of Nadolol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 unknown. 5 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 4, Unknown 1
Phase 11Completed 1

Follow Nadolol: new trials by email Literature Review of Nadolol trials Research Report on Nadolol

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Disorders
clenbuterol (CST-103), nadolol (CST-107), matching placebo - Mild Cognitive Impairment, Lewy Body Dementia, Parkinson's Disease Rapid Eye Movement Sleep Behavior Disorder, Parkinson's Disease Dementia
Phase 2CompletedCuraSen Therapeutics, Inc.412021-06-282024-12-02
Efficacy and Safety of Βeta-adrenoceptor Inverse Agonist and Biased Ligand, Nadolol, In Smoking Cessation of Patients With Chronic Cough With or Without Airflow Obstruction
Nadolol, Placebo - Smoking Cessation
Phase 2CompletedInvion, Inc.1552014-03-012017-02-01
Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma
Nadolol, Placebo - Mild Persistent Asthma, Uncomplicated
Phase 2UnknownInvion, Inc.602013-03-012016-08-09
Nadolol for Proliferating Infantile Hemangiomas
Nadolol - Infantile Hemangioma
Phase 2CompletedThe Hospital for Sick Children202009-11-012021-08-19
Oral Nadolol for the Treatment of Adults With Mild Asthma
nadolol - Asthma
Phase 1 / Phase 2CompletedInvion, Inc.102007-01-012016-05-11

Conditions studied

Asthma (1)  ·  Cognitive Dysfunction (1)  ·  Hemangioma, Capillary (1)  ·  Lewy Body Disease (1)  ·  Smoking Cessation (1)

Sponsors

Invion, Inc. (3)  ·  CuraSen Therapeutics, Inc. (1)  ·  The Hospital for Sick Children (1)

Countries

United States (3)  ·  Australia (1)  ·  Canada (1)  ·  New Zealand (1)  ·  United Kingdom (1)

Top investigators

Elena Pope, MD (1)  ·  Mario Castro, M.D. (1)  ·  Nicola A Hanania, MD (1)  ·  Nicola A. Hanania, MD, MS (1)